A Randomized Clinical Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Acute Coronary Syndrome Patients: The TARGET-D Trial - report from AHA 2025

Professor Heidi T. May explains heart attack risk halved in adults with heart disease taking tailored vitamin D doses at AHA Scientific Sessions 2025.

Video: https://medicaldigest.org/scientific-contents/interview:randomized-clinical-trial-evaluating-vitamin-d-normalization-major-adverse-cardiovascular-related-events-among-acute-coronary-syndrome-patients-target-d-trial